Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Datopotamab deruxtecan (ADC) (DHC43399)

Applications:Research Grade Biosimilar
Overview

Catalog No.

DHC43399

Description

Datopotamab deruxtecan is an ADC consisting of a TROP2-directed antibody and Dxd, a topoisomerase I inhibitor, used for the study of breast cancer.

Species reactivity

Human

Clonality

Monoclonal

Target

Trop2

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SEC.

Purification

Purified by Ion Exchange Chromatography.

Applications

Research Grade Biosimilar

Form

Liquid

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

DS-1062a

Clone ID

Datopotamab deruxtecan

Data Image
References
Datasheet

Document Download

Datopotamab deruxtecan (ADC).pdf

 

$ 2540
Product specifications
1 mg 2540 5 mg 6360

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Datopotamab deruxtecan (ADC) [DHC43399]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only